CHAT and Alzheimer disease: The results of the present study revealed that intracerebroventricular injection of STZ mimicked AD like behavioral changes including decreased time spent in the fourth quadrant, enhanced escape latency in the Morris water maze test, decreased retention latency in the passive avoidance test, impaired oxidative status accompanied by increased pro-inflammatory cytokines and decreased ChAT expression in the hippocampus.